JamesV.UyekiMD

Oncology • Austin, TX

Physician

Join to view full profile

Dr. Uyeki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Uyeki's full profile

Already have an account?

Office
4101 James Casey St
Ste 100
Austin, TX 78745
Phone+1 512-447-2202

Fax+1 512-447-5337

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
University of California (San Francisco)Residency, Internal Medicine, 1997 - 2000
New York University School of MedicineClass of 1997

Certifications & Licensure

CA State Medical License 1999 - Present
OR State Medical License 2001 - Present
TX State Medical License 2004 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11
Terminated
Phase 3
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Start of enrollment: 2011 Jan 16
Completed
Phase 3
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2015 Nov 23
Completed
Phase 1, Phase 2
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Completed
Phase 2
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) Start of enrollment: 2016 Sep 13
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma
William N. William, James Uyeki, Faye M. Johnson, Lei Feng, Beverly O. Peeples
Cancer. 2010-05-15
10 citations
Mouse embryo fibroblasts transformed by activated ras or dominant-negative p53 express cross-reactive tumor rejection antigens.
Leonard Joseph Appleman, James Uyeki, Alan B. Frey
International Journal of Cancer. 1995-06-09

Press Mentions

Mike Diers: Fighting Cancer with the Power of PerspectiveNovember 14th, 2021
Mike Downey: Fighting Cancer for the Ride of His LifeFebruary 7th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member